TCL Archive ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials By Cancer History Project December 31, 2010
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase By Cancer History Project December 31, 2010
TCL Archive Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint By Cancer History Project December 31, 2010
TCL Archive Autologous BMT Equivalent To Allogeneic For Myeloma By Cancer History Project December 31, 2010
TCL Archive Non-Adherence To Protocol Explains Outcome Differences In Hispanic Children With ALL By Cancer History Project December 31, 2010
TCL Archive Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study By Cancer History Project December 31, 2010
TCL Archive AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III By Cancer History Project December 31, 2010
TCL Archive Survival For ALL Increased To 94 Percent In Recent Years By Cancer History Project December 31, 2010
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
